BRIEF published on 03/03/2025 at 14:06, 1 year ago Mainz Biomed Pushes for Colorectal Cancer Prevention Early Detection Mainz Biomed Colorectal Cancer Prevention Screening Solutions
PRESS RELEASE published on 03/03/2025 at 14:01, 1 year ago Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention Mainz Biomed N.V. advocates for a shift from screening to prevention during Colorectal Cancer Awareness Month, emphasizing early detection and innovative diagnostic solutions Diagnostic Solutions Mainz Biomed Colorectal Cancer Prevention Awareness Month
BRIEF published on 02/20/2025 at 14:06, 1 year 1 month ago Mainz Biomed s'étend en Suisse avec un nouveau partenariat Mayence Biomed Dépistage Du Cancer Colorectal Alerte Colo L'expansion De La Suisse Diagnostic ADN
BRIEF published on 02/20/2025 at 14:06, 1 year 1 month ago Mainz Biomed Expands into Switzerland with New Partnership ColoAlert Mainz Biomed Colorectal Cancer Screening Switzerland Expansion DNA Diagnostics
PRESS RELEASE published on 02/20/2025 at 14:01, 1 year 1 month ago Mainz Biomed Expands into Switzerland with labor team w Mainz Biomed partners with labor team in Switzerland to launch DNA-based colorectal cancer screening test, expanding presence in European market Switzerland Mainz Biomed Colorectal Cancer Labor Team DNA-based Test
BRIEF published on 02/11/2025 at 14:06, 1 year 1 month ago Mainz Biomed et GANZIMMUN lancent le dépistage amélioré ColoAlert Innovation Dans Le Domaine De La Santé Dépistage Du Cancer Lancement De ColoAlert Directives Pour L'Allemagne Tampon D'ADN
BRIEF published on 02/11/2025 at 14:06, 1 year 1 month ago Mainz Biomed and GANZIMMUN Launch Enhanced ColoAlert Screening Healthcare Innovation Cancer Screening ColoAlert Launch Germany Guidelines DNA Buffer
PRESS RELEASE published on 02/11/2025 at 14:01, 1 year 1 month ago Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month Mainz Biomed and GANZIMMUN launch enhanced ColoAlert colorectal cancer screening ahead of awareness month, providing broader access and innovative diagnostics Germany ColoAlert Mainz Biomed Colorectal Cancer Screening GANZIMMUN
BRIEF published on 01/27/2025 at 14:06, 1 year 1 month ago Mainz Biomed retrouve sa conformité au Nasdaq ColoAlert® Mayence Biomed Conformité Au Nasdaq Diagnostic Du Cancer Exigences En Matière De Fonds Propres
BRIEF published on 01/27/2025 at 14:06, 1 year 1 month ago Mainz Biomed Regains Nasdaq Compliance Nasdaq Compliance Cancer Diagnostics Mainz Biomed ColoAlert® Equity Requirements
Published on 03/20/2026 at 13:30, 2 days 11 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 12 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 12 hours 16 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 1 hour ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 3 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 3 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 5 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 5 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 6 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 6 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
